ACLY and prostate cancer: Recent studies have found that Cu B can exert anticancer effects by inducing apoptosis and cell cycle arrest in human prostate cancer PC3 cells through down-regulation of the JAK/STAT signaling pathway [16], as well as inhibiting prostate cancer growth by inactivating ATP-citrate lyase [17].